Leo Pharma AS - Strategic SWOT Analysis Review

Leo Pharma AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description - A detailed description of the company's operations and business divisions.
• Corporate strategy - The publisher's summarization of the company's business strategy.
• SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives' employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

LEO Pharma AS (LEO Pharma), a subsidiary of LEO Foundation, is a drug manufacturing company. It discovers, develops, manufactures, and commercializes medicines for skin diseases and thrombosis. Its product portfolio spans pharmaceuticals for the treatment of diseases such as eczema, psoriasis, skin infections, actinic keratosis, non-melanoma skin cancer and thrombosis. The company also manufactures and markets products for the treatment of bacterial infections, coagulation, cardiovascular, antibiotics, nutritional disorders, osteoporosis, and renal problems. LEO Pharma markets its products worldwide. The company has a presence in Europe, the Middle East, Africa, Asia, the Americas, and Oceania. LEO Pharma is headquartered in Ballerup, Denmark.

Leo Pharma AS Key Recent Developments

• Sep 29, 2022: LEO Pharma and DKSH Partner to deliver products and solutions to people in Asia with skin conditions and thrombosis
• Jun 15, 2022: Vipergen and LEO Pharma partner for DNA Encoded Library (DEL)-based drug discovery for dermatology indications
• Apr 27, 2022: Leo Pharma leverages Veeva Link for Key People to expand engagement with scientific experts
• Apr 21, 2022: LEO Pharma's emission reduction targets validated by the Science based targets initiative
• Feb 17, 2022: LEO Pharma appoints Brian Hilberdink new president of LEO Pharma United States

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors' business structure and strategies with the publisher's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.